Pre-exposure (PrEP)
Pre-exposure Prophylaxis (PrEP)
More iPrEx and OLE Data Published: Adherence Higher in U.S.
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 26 September 2014 00:00
- Written by Liz Highleyman
Participants enrolled at the U.S. study sites of the global iPrEx trial of Truvada pre-exposure prophylaxis (PrEP) achieved better adherence than those in other countries, reaching 90% in San Francisco, researchers reported in the September 16 advance edition of Journal of Acquired Immune Deficiency Syndromes. Findings from the iPrEx open-label extension (OLE) were also recently published.
PrEP Rally: As Numbers Rise, Advocates Want Wider Access
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 19 September 2014 00:00
- Written by Liz Highleyman
The number of people using pre-exposure prophylaxis, or PrEP, to prevent HIV infection has risen steadily over the past year, according to data presented this week at a San Francisco community engagement forum. But PrEP advocates -- including 3 city supervisors -- say more needs to be done to overcome barriers to access for all who want it.
PrEP by the Numbers: Interpreting Conflicting Study Data
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Monday, 15 September 2014 00:00
- Written by Liz Highleyman
A recent ad campaign from the AIDS Healthcare Foundation has kicked off a new round of controversy about HIV pre-exposure prophylaxis (PrEP) and how to interpret apparently conflicting numbers from prevention studies.
ICAAC 2014: Tenofovir Vaginal Ring and Nanoparticle Gel Are Protective in Animal Studies
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Tuesday, 16 September 2014 00:00
- Written by Liz Highleyman
A vaginal ring that dispenses tenofovir protected all 6 macaque monkeys exposed to an HIV-like virus, while a heat-sensitive vaginal gel containing tenofovir nanoparticles prevented infection of mice, researchers reported at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy last week in Washington, DC.
Counseling Helps Improve PrEP Adherence Among Serodiscordant Couples
- Details
- Category: HIV Prevention
- Published on Thursday, 04 September 2014 00:00
- Written by Liz Highleyman
Cognitive-behavioral counseling sessions significantly increased the likelihood of consistently taking pills among participants with faltering adherence in an African trial of Truvada pre-exposure prophylaxis (PrEP) for serodiscordant (mixed HIV status) heterosexual couples, according to a report in the August 15 Journal of Acquired Immune Deficiency Syndromes.
Web Design and Development by